ipamorelin what is it uses side effects Peptides are gaining popularity, but

Boston Vitalitys model points in the right direction for patients who want premium, localized, hormone-focused care: specialist-led positioning, clear anti-aging and vitality branding, and peptide therapy offered as part of their broader health strategy rather than a magic fix

CJC-1295 No DAC & Ipamorelin vs MK-677: Research Application Comparison Key Takeaways CJC-1295 no DAC binds GHRH receptors to trigger pulsatile GH release over 68 day half-life, while Ipamorelin amplifies those pulses via ghrelin receptor agonism without cortisol or prolactin elevation

This negative feedback loop forms part of the GH-IGF-1 axis

The Short Answer If you are choosing between growth-hormone peptides in 2026, your real decision is between two approaches

Evidence snapshot: The strongest human evidence comes from a 2-year randomized controlled trial in 65 healthy older adults (Nass et al., 2008, Annals of Internal Medicine) showing sustained GH/IGF-1 increases and preserved fat-free mass, plus an earlier short-term human polysomnography study on sleep (Copinschi et al., 1997, Neuroendocrinology, PMID 9349662)

R., et al